Logo-ps
Pharm Sci. 2020;26(Covid-19): S80-S81. doi: 10.34172/PS.2020.53

Commentary

Dexmedetomidine: An All Sedation-in–One Drug in Critically Ill Patients with COVID-19

Ata Mahmoodpoor 1, Elyad Ekrami 2, Hassan Soleimanpour 3 * ORCID

Cited by CrossRef: 1


1- Tahsini Tekantapeh S, Ghojazadeh M, Ghamari A, Mohammadi A, Soleimanpour H. Therapeutic and anti-inflammatory effects of baricitinib on mortality, ICU transfer, clinical improvement, and CRS-related laboratory parameters of hospitalized patients with moderate to severe COVID-19 pneumonia: a systematic review and meta-analysis. Expert Review of Respiratory Medicine. 2022;16(10):1109 [Crossref]